Participate in a Study

Patients who participate in clinical trials have the first chance to benefit from treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about the disease. Although clinical trials may pose some risk, researchers take careful steps to protect people who take part.

We have clinical trials testing drugs that may prevent relapse in patients whose kidney cancer was removed but who remain at risk. We also have several trials of novel therapies, including immune system treatments for patients with advanced or metastatic kidney cancer.

• For more information about clinical studies, see the Patient Guide to Clinical Trials.
• Check here for a list of the current clinical trials for renal cell carcinoma at SCCA
• For patients with advanced disease, check the current roster of open Phase 1 Trials.